Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APOSTEL VIII: atosiban versus placebo for late threatened preterm birth
NL-OMON54673Phase 3Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Preterm labor (PTL) and preterm birth comparing Atosiban with Placebo (2 arms). Primary endpoint: Combined perinatal outcome of severe neonatal morbidity and perinatal mortality. Started Dec 2017; status: recruiting.
02
Drugs
atosiban
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on NL-OMON54673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54673.